Search results
Which Is the Better Cancer-Testing Healthcare Stock: Exact Sciences or Guardant Health?
Motley Fool· 8 months agoExact Sciences (NASDAQ: EXAS) and Guardant Health (NASDAQ: GH) make diagnostic tests to help screen...
If You Invested $1000 in Exact Sciences a Decade Ago, This is How Much It'd Be Worth Now
Zacks via Yahoo Finance· 6 months agoFor most investors, how much a stock's price changes over time is important. This factor can impact...
UK NICE backs Exact’s Oncotype cancer genomic test
Medical Device Network via Yahoo Finance· 4 weeks agoThe UK’s National Institute for Health and Care Excellence (NICE) has recommended the use of Exact Sciences’s genomic test Oncotype DX breast recurrence...
Here's How Much a $1000 Investment in Exact Sciences Made 10 Years Ago Would Be Worth Today
Zacks via Yahoo Finance· 11 months agoHow much a stock's price changes over time is important for most investors, since price performance...
Exact Sciences (EXAS) Q3 Earnings Top Estimates, Margin Falls
Zacks via Yahoo Finance· 2 years agoExact Sciences Corporation EXAS reported a net loss of 84 cents per share for third-quarter 2022,...
Decoding Exact Sciences Corp (EXAS): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 4 weeks agoExact Sciences Corp's revenue growth reflects its strong market position in cancer diagnostics....
Exact Sciences Corporation (NASDAQ:EXAS) Q2 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 10 months agoExact Sciences Corporation (NASDAQ:EXAS) Q2 2023 Earnings Call Transcript August 1, 2023 Exact...
Everything Advisors Need to Know About ARKG’s Q2 Performance
ETF Trends via Yahoo Finance· 2 years agoThe ARK Genomic Revolution ETF (ARKG) has rebounded in the past five weeks, partially offsetting...
Cathie Wood Has Bet Big On These 10 Stocks; Here's How They Performed In 2022
Investor's Business Daily· 1 year agoCathie Wood, CEO and founder of Ark Invest, says she invests on a five-year time horizon, betting...
Q3 2023 Exact Sciences Corp Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 7 months agoParticipants Erik Holznecht; Senior IR Associate; Exact Sciences Corporation Everett V. Cunningham; Chief Commercial Officer; Exact Sciences Corporation Jeffrey T. Elliott; Executive VP & CFO ...
